Drug Trial Radar · NCT06641180
Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age
Last checked: Nov 19, 2026Latest source record: Dec 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,180
Actual
Start
Nov 4, 2024
Primary completion
Jan 28, 2025
Study completion Jun 24, 2025
Sponsor
- Lead sponsor
- Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
- Sponsor type
- Industry
- First posted
- Oct 15, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate Immunogenicity and Safety of a High-Dose (HD) Influenza Vaccine (IV) in Adults 50 through 64 Years of Age.
Conditions
- Influenza
Interventions
High-Dose trivalent influenza vaccine (Split virion, Inactivated)Biological
Liquid suspension for intramuscular injection
Standard-dose trivalent influenza vaccine (Split virion, Inactivated)Biological
Liquid suspension for intramuscular injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Geometric mean titers (GMTs) against influenza vaccine antibodies (Ab)Time frame: Day 1 and Day 29
- Percentage of participants with seroconversion for influenza vaccine antibodiesTime frame: Day 29
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
CenExel CNS- Site Number : 8400005
Los Alamitos, California
Alliance for Multispeciality Research - Fort Myers- Site Number : 8400019
Fort Myers, Florida
Research Centers of America - Hollywood- Site Number : 8400010
Hollywood, Florida
IACT Health - Columbus - Talbotton Road- Site Number : 8400011
Columbus, Georgia
Cenexel IRA - iResearch Atlanta- Site Number : 8400007
Decatur, Georgia
The Hope Clinic of Emory Vaccine Center- Site Number : 8400017
Decatur, Georgia
Centricity Research - Rincon- Site Number : 8400012
Rincon, Georgia
Cenexel IRS - iResearch Savannah- Site Number : 8400008
Savannah, Georgia
Alliance for Multispeciality Research - Newton- Site Number : 8400003
Newton, Kansas
Alliance for Multispeciality Research - Lexington- Site Number : 8400002
Lexington, Kentucky
CBH Health - Gaithersburg- Site Number : 8400004
Gaithersburg, Maryland
Hassman Research Institute - Berlin- Site Number : 8400006
Berlin, New Jersey
Centricity Morehead- Site Number : 8400014
Morehead City, North Carolina
Centricity New Bern- Site Number : 8400015
New Bern, North Carolina
Aventiv Research Columbus- Site Number : 8400016
Columbus, Ohio
Kaiser Permanente Center for Health Research- Site Number : 8400018
Portland, Oregon
Alliance for Multispecialty Research - Volunteer Research Group- Site Number : 8400001
Knoxville, Tennessee
JBR Clinical Research- Site Number : 8400009
Salt Lake City, Utah
Centricity Research - Suffolk Primary Care - Centricity - PPDS- Site Number : 8400013
Suffolk, Virginia
Kaiser Permanente Washington- Site Number : 8400024
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.